Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
45°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Spruce Biosciences, Inc. - Common Stock
(NQ:
SPRB
)
0.1187
-0.0043 (-3.50%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Spruce Biosciences, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
Spruce Biosciences Completes Target Enrollment of CAHmelia-203 Study in Adult Classic Congenital Adrenal Hyperplasia
October 18, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Spruce Biosciences Inc. (NASDAQ: SPRB) Making Surprising Moves in Tuesday Session
September 12, 2023
Via
Investor Brand Network
Why Hooker Furnishings Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
September 08, 2023
Gainers Biocept, Inc. (NASDAQ: BIOC) shares jumped 97.6% to $1.6608 after the company announced non-exclusive licensing agreement for CNSide with Plus Therapeutics.
Via
Benzinga
Analyst Ratings for Spruce Biosciences
September 08, 2023
Via
Benzinga
Expert Ratings for Spruce Biosciences
August 16, 2023
Via
Benzinga
Analyst Expectations for Spruce Biosciences's Future
May 16, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2023
September 08, 2023
Via
Benzinga
Why Smith & Wesson Brands Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
September 08, 2023
Gainers Impel Pharmaceuticals Inc. (NASDAQ: IMPL) rose 41.3% to $0.54 in pre-market trading after falling 4% on Thursday.
Via
Benzinga
Adobe To Rally Over 12%? Here Are 10 Other Analyst Forecasts For Friday
September 08, 2023
B of A Securities cut the price target for DigitalOcean Holdings, Inc. (NYSE: DOCN) from $47 to $25. B of A Securities analyst Wamsi Mohan downgraded the stock from Buy to Underperform. DigitalOcean...
Via
Benzinga
4 Analysts Have This to Say About Spruce Biosciences
March 23, 2023
Via
Benzinga
Spruce Biosciences to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
August 28, 2023
From
Spruce Biosciences
Via
Business Wire
Spruce Biosciences Reports Second Quarter 2023 Financial Results and Provides Corporate Updates
August 14, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
July 27, 2023
Via
Benzinga
Spruce Biosciences Announces Acceptance of Abstract for Presentation at the Annual Meeting of the Endocrine Society (ENDO 2023)
June 12, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Spruce Biosciences Appoints Percival Barretto-Ko to Board of Directors
May 25, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Spruce Biosciences to Participate in the Jefferies Healthcare Conference
May 24, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Spruce Biosciences Honored at CARES Foundation 15th Annual Everyone CARES Gala
May 22, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Spruce Biosciences Reports First Quarter 2023 Financial Results and Provides Corporate Updates
May 15, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Spruce Biosciences to Present Findings on Retrospective Analysis of Completion Rates for CAH Studies at Pediatric Endocrine Society 2023 Annual Meeting
May 04, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Spruce Biosciences to Participate in May Investor Conferences
May 02, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
89bio To Rally 265%? Here Are 10 Other Analyst Forecasts For Thursday
March 23, 2023
Baird cut the price target for Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) from $14 to $11. Baird analyst Justin Kleber maintained an Outperform rating. Petco Health and Wellness shares rose...
Via
Benzinga
Spruce Biosciences Reports Full Year 2022 Financial Results and Provides Corporate Updates
March 16, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Spruce Biosciences to Participate in the Oppenheimer 33rd Annual Healthcare Conference
February 28, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
$7M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Buying
February 22, 2023
The Dow Jones closed lower by around 700 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 22, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
February 09, 2023
Via
Benzinga
Spruce Biosciences Announces $53.6 Million Private Placement Financing
February 09, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Spruce Biosciences to Participate in the SVB Securities Global Biopharma Conference
February 01, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Peering Into Spruce Biosciences's Recent Short Interest
January 09, 2023
Spruce Biosciences's (NASDAQ:SPRB) short percent of float has risen 17.3% since its last report. The company recently reported that it has 588 thousand shares sold short, which is 3.39% of all regular...
Via
Benzinga
Spruce Biosciences Provides Clinical Program Updates and Outlines Anticipated Milestones for 2023
January 09, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.